Skip to main navigation Skip to search Skip to main content

Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

  • Genetic Risk and Outcome of Psychosis (GROUP) investigators
  • University of Pavia
  • University of Health Sciences
  • Maastricht University Medical Center (MUMC+)
  • Mondriaan Mental Health Centre
  • University Medical Centre Utrecht
  • GGNet Mental Health
  • Cardiff University
  • Dokuz Eylul University
  • Adnan Menderes University
  • Ankara University
  • Neuroscience and Neurotechnology Center of Excellence (NÖROM)
  • Middle East Technical University (METU)
  • Turkish Federation of Schizophrenia Associations
  • Güven Çayyolu Healthcare Campus
  • Faculty of Medicine University of Belgrade
  • Clinical Centre of Serbia
  • Institute of Mental Health
  • Special Hospital for Psychiatric Disorders Kovin
  • University of Barcelona
  • Institut d’Investigacións Biomèdiques August Pi i Sunyer (IDIBAPS)
  • Biomedical Research Networking Centre in Mental Health (CIBERSAM)
  • University of Oviedo
  • Instituto de Investigación Sanitaria del Principado de Asturias
  • Mental Health Services of Principado de Asturias
  • Universidad de Valencia
  • Hospital Virgen de la Luz
  • Universidad Castilla La Mancha
  • Complejo Hospitalario Universitario de Santiago
  • Universidade de Santiago de Compostela
  • Fundación Pública Galega de Medicina Xenómica (SERGAS)
  • Hospital General Universitario Gregorio Marañón
  • Istanbul University
  • King's College London
  • Yale School of Medicine

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Background: People with schizophrenia spectrum disorders (SSD) frequently present cognitive impairments. Here, we investigated whether the exposome score for schizophrenia (ES-SCZ) - a cumulative environmental exposure score - was associated with impairments of neurocognition, social cognition, and perception in patients with SSD, their unaffected siblings, and healthy controls. Methods: This cross-sectional sample consisted of 1200 patients, 1371 siblings, and 1564 healthy controls. Neurocognition, social cognition, and perception were assesed using a short version of the Wechsler Adult Intelligence Scale–Third Edition (WAIS-III), the Degraded Facial Affect Recognition Task (DFAR), and the Benton Facial Recognition Test (BFR), respectively. Regression models were used to analyze the association between ES-SCZ and cognitive domains in each group. Results: There were no statistically significant associations between ES-SCZ and cognitive domains in SSD. ES-SCZ was negatively associated with T-score of cognition in siblings (B=-0.40, 95% CI -0.76 to -0.03) and healthy controls (B=-0.63, 95% CI -1.06 to -0.21). Additionally, ES-SCZ was positively associated with DFAR-total in siblings (B=0.83, 95% CI 0.26 to 1.40). Sensitivity analyses excluding cannabis use history from ES-SCZ largely confirmed the main findings. Conclusions: Longitudinal cohorts may elucidate how environmental exposures influence the onset and course of cognitive impairments in trans-syndromic psychosis spectrum.

Original languageEnglish
Article number115184
JournalPsychiatry Research
Volume323
DOIs
Publication statusPublished - May 2023

Keywords

  • Cannabis use
  • Childhood trauma
  • Emotion recognition
  • Environment
  • Psychosis

Fingerprint

Dive into the research topics of 'Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study'. Together they form a unique fingerprint.

Cite this